PERSPECTA

News from every angle

← Back to headlines

EyePoint Pharmaceuticals GAAP EPS of -$0.81 misses by $0.08, revenue of $0.62M misses by $0.39M

4 Mar, 12:04 — 4 Mar, 12:04
PostShare
Only 1 source covers this story